Company: HCTI
Filing Date: 2025-03-05
Form Type: PRE 14C
Source: 0001213900-25-020571
Chunk: 3

Company: Healthcare Triangle, Inc.
Filing Date: 2025-03-05
Form: PRE 14C
Chunk 3
---
 borne by the Company. We will request brokerage houses, nominees, custodians, fiduciaries and other like parties to
forward this Information Statement to the beneficial owners of the shares of stock held of record by them.

<div align='center'>AUTHORIZATION BY THE BOARD OF DIRECTORS

AND THE MAJORITY STOCKHOLDERS</div>

Under the DGCL and the Company’s Bylaws,
any action that can be taken at an annual or special meeting of stockholders may be taken without a meeting, without prior notice and
without a vote, if the holders of outstanding stock having not less than the minimum number of votes that will be necessary to authorize
or take such action at a meeting at which all shares entitled to vote thereon were present and voted to consent to such action in writing.
The approval of the Corporate Actions requires the affirmative vote or written consent of a majority of the voting power of the issued
and outstanding shares of stock. Each holder of Common Stock is entitled to one vote per share of Common Stock held of record on any
matter which may properly come before the Stockholders.

On the Record Date, the Company had 8,295,819
shares of Common Stock, and 6,000 shares of our Series A Preferred Stock issued and outstanding. The holders of our outstanding
shares of Common Stock are entitled to one vote per share registered in their names on our books at the close of business on such date.
The holder of the Series A Preferred Stock is entitled to vote with the Company’s Common stock at a rate of 1,000 votes per share.
On February 24, 2025, the Majority Stockholders adopted resolutions approving the Corporate Actions.

<div align='center'>CONSENTING STOCKHOLDERS</div>

On February 24, 2025, the Majority Stockholders,
being the record holders of an aggregate of 2,625,000 shares (approximately 18.36%) of our outstanding shares of Common Stock and all
of the 6,000 shares of Series A Preferred Stock having an aggregate of 6,000,000 votes (and together with the Common Stock that such
stockholder voted, representing approximately 59.81% of the shares entitled to vote thereon) on February 24, 2025, consented in writing
to the Corporate Actions. Accordingly, all Corporate Actions were authorized and approved as of the Record Date.

We are not seeking written consent from any other
Stockholder of the Company, and the other Stockholder